NRAMP study on antipsychotic medication during pregnancy published

The results of a seven-year study of women who take antipsychotic medication while pregnant have recently been published on PLOS ONE.

The study revealed that whilst most women gave birth to healthy babies, the use of mood stabilisers or higher doses of antipsychotics during pregnancy increased the need for special care after birth. MAPrc established the world-first National Register of Antipsychotic Medications in Pregnancy (NRAMP) in 2005 to collect data on antipsychotic medication and pregnancy. The study highlights the need for clearer health guidelines when antipsychotic drugs are taken during pregnancy. An overview of the study can be found on Monash University News and events, ABC Science or Futurity and the original article can be found on PLOS ONE.